Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1363-1367

  Yoon, Sang Jin ^a   Park, Inae ^b   Kwak, Cheol ^b   Lee, Eunsik ^b  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Bladder cancer; Cisplatin; Drug resistance; Ultrastructural change

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; BLADDER TUMOR; CELL MEMBRANE; CHEMISTRY; CHROMATIN; CYTOPLASM; DRUG RESISTANCE; ELECTRON MICROSCOPY; HUMAN; IC 50; METABOLISM; MITOCHONDRION; RIBOSOME; ROUGH ENDOPLASMIC RETICULUM; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MEMBRANE; CHROMATIN; CISPLATIN; CYTOPLASM; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM, ROUGH; HUMANS; INHIBITORY CONCENTRATION 50; MICROSCOPY, ELECTRON; MITOCHONDRIA; RIBOSOMES; URINARY BLADDER NEOPLASMS;

EID: 2142688127     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1363     Document Type: Article

References (21)

1. Perry JJ and Muss HB: Management of disseminated disease in the patient with bladder cancer. Urol Clin North Am 21: 661-672, 1994. (Pubitemid 24370161)
2. Wang Y, Teicher BA, Shea TC, et al: Cross-resistance and glutathione-s-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 49: 6185-6192, 1989. (Pubitemid 20000907)
3. Plooy ACM, van Dijk M and Lohman PHM: Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Cancer Res 44: 2043-2051, 1984. (Pubitemid 14145150)
4. Richon VM, Schute N and Eastman A: Multiple mechanisms of resistance to cis-diamminedichloroplantinum (II) in murine leukemia L1210 cells. Cancer Res 47: 2056-2061, 1987. (Pubitemid 17074608)
5. Waud WR: Differential uptake of cis-diamminedichloroplantinum (II) by sensitive and resistance murine L1210 leukemia cells. Cancer Res 47: 6449-6465, 1987.
6. Lai GM, Ozols RF, Young RC, et al: Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J Natl Cancer Inst 81: 535-539, 1989. (Pubitemid 19102224)
7. Hospers GA, Meijer C, De Leij J, Uges DRA, Mulder NH and De Vries EGE: A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance. Int J Cancer 46: 138-144, 1990. (Pubitemid 20225800)
8. Teicher BA, Holden SA, Kelley MJ, et al: Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum (II). Cancer Res 47: 388-393, 1987. (Pubitemid 17009596)
9. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-941, 1987.
10. Zamora JM and Beck WT: Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells. Biochem Pharmacol 35: 4303-4310, 1986. (Pubitemid 17204102)
11. Dietel M, Arps H, Lage H and Niendorf A: Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 50: 6100-6106, 1990. (Pubitemid 20331427)
12. Erlandson RA: The nucleus. In: Diagnostic Transmission Electron Microscopy of Tumors. Erlandson RA (ed). Raven, New York, pp69-86, 1994.
13. Zini N, Scotlandi K, Baldini N, Nini G, Sabatelli P and Maraldi N: Multidrug-resistance (MDR) phenotype of human osteosarcoma cells evaluated by quantitative morphological and electron microscopy analyses. Biol Cell 84: 195-204, 1995. (Pubitemid 26017547)
14. Erlandson RA: The Cytoplasm. In: Diagnostic Transmission Electron Microscopy of Tumors. Erlandson RA (ed). Raven, New York, pp87-187, 1994.
15. Andrews PA and Albright KD: Mitochondrial defects in cis- diamminedichloroplatinum (Il)-resistant human ovarian carcinoma cells. Cancer Res 52: 1895-1901, 1992.
16. Melguizo C, Prados J, Aneiros J, Fernandez JE, Velez C and Aranega A: Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment. J Pathol 175: 23-29, 1995.
17. Arsenault AL, Ling V and Kartner N: Altered plasma membrane ultrastructure in multidrug-resistant cells. Biochim Biophys Acta 938: 315-321, 1988.
18. Sehested M, Skovsgaard T, van Deurs B and Winther-Nielsen H: Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br J Cancer 56: 747-751, 1987. (Pubitemid 18048345)
19. Erlandson RA: The cell surface. In: Diagnostic Transmission Electron Microscopy of Tumors. Erlandson RA (ed). Raven, New York, pp188-220, 1994.
20. Cornwell MM, Gottesman MM and Pastan IH: Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem 261: 7921-7928, 1986. (Pubitemid 17208724)
21. Schnipper LE: Clinical implications of tumor-cell heterogeneity. N Engl J Med 314: 1423-1431, 1986.